The Financial Growth and Success of Alkaloid
Explore the financial trajectory of Alkaloid AD Skopje over the past five years, highlighting key metrics such as revenue, profit before income tax, and employee growth. Discover how this Macedonian pharmaceutical giant has climbed the ranks to become one of the most successful companies in the region.
Alkaloid AD Skopje, a leading pharmaceutical company in North Macedonia, has shown impressive financial growth and operational success over the past five years. This analysis delves into the key financial metrics, including revenue, profit before income tax, company rankings, and employee numbers from 2019 to 2023.
Over the five-year period, Alkaloid's revenue has consistently increased. In 2019, the company reported a revenue of 8.68 billion MKD, which grew to 12.90 billion MKD by 2023. This steady increase in revenue underscores Alkaloid's strong market position and effective business strategies.
2019: 8,675,497,783 MKD
2020: 9,597,973,072 MKD
2021: 10,016,173,140 MKD
2022: 11,564,381,015 MKD
2023: 12,896,034,873 MKD
The company's profit before income tax also saw a notable rise, reflecting efficient cost management and profitability. From 1.13 billion MKD in 2019, Alkaloid's profit before tax reached 1.65 billion MKD in 2023.
2019: 1,128,788,338 MKD
2020: 1,248,013,825 MKD
2021: 1,387,841,594 MKD
2022: 1,533,127,829 MKD
2023: 1,651,838,699 MKD
Alkaloid's performance has also been recognized in its rankings among the largest and most successful companies in North Macedonia. Notably, the company improved its position in the rank of most successful companies from 10th in 2019 to 5th in 2023, illustrating its growing impact and market leadership.
Rank Largest:
2019: 12
2020: 11
2021: 14
2022: 18
2023: 10
Rank Successful:
2019: 10
2020: 9
2021: 9
2022: 8
2023: 5
Employee numbers at Alkaloid have steadily increased, indicating the company's expansion and commitment to job creation. From 1,588 employees in 2019, the workforce grew to 2,037 by 2023.
2019: 1,588
2020: 1,737
2021: 1,860
2022: 1,965
2023: 2,037
Alkaloid AD Skopje's financial performance over the past five years showcases a trajectory of growth, efficiency, and success. The company's ability to increase revenue and profit while climbing the ranks of the largest and most successful companies in North Macedonia is a testament to its robust business model and strategic vision. As Alkaloid continues to expand its workforce, it also strengthens its role as a key player in the pharmaceutical industry, both locally and regionally.
31-07-2025
Multi Shped: Growth Through Green Logistics, Trust, and International Partnerships
Multi Shped strengthens its logistics presence through reliable deliveries, green investments, and strategic partnerships with firms like Militzer & Münch. As part of the 200 LARGEST AND SUCCESSFUL, the company affirms its leadership in 2025.
30-07-2025
TDR Skopje Shows Stable Growth and Increased Profitability in Tobacco Trade
In 2023, TDR Skopje achieved revenue of 3.11 billion MKD and profit of 22.3 million MKD, recording a 9.69% revenue increase and a significant 54.96% boost in profitability.
30-07-2025
